MLK inhibitors and methods of use

Provided are compounds having an inhibitory effect on Mixed Lineage Kinases. Also provided are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating dis...

Full description

Saved in:
Bibliographic Details
Main Authors GELBARD HARRIS A, LOWETH COLIN J, GOODFELLOW VAL S, DEWHURST STEPHEN, WIEMANN TORSTEN
Format Patent
LanguageEnglish
Published 11.02.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Provided are compounds having an inhibitory effect on Mixed Lineage Kinases. Also provided are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by Mixed Lineage Kinase inhibition. Also provided are methods of treatment of neuropsychiatric disorders which comprise the inhibition of Mixed Lineage Kinases.
AbstractList Provided are compounds having an inhibitory effect on Mixed Lineage Kinases. Also provided are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by Mixed Lineage Kinase inhibition. Also provided are methods of treatment of neuropsychiatric disorders which comprise the inhibition of Mixed Lineage Kinases.
Author GELBARD HARRIS A
DEWHURST STEPHEN
GOODFELLOW VAL S
WIEMANN TORSTEN
LOWETH COLIN J
Author_xml – fullname: GELBARD HARRIS A
– fullname: LOWETH COLIN J
– fullname: GOODFELLOW VAL S
– fullname: DEWHURST STEPHEN
– fullname: WIEMANN TORSTEN
BookMark eNrjYmDJy89L5WRQ9PXxVsjMy8hMyizJLypWSMxLUchNLcnITylWyE9TKC1O5WFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8c5-hgZGRmYm5ibGTk7GRCkCAG30J1A
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN102264743BB
GroupedDBID EVB
ID FETCH-epo_espacenet_CN102264743BB3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN102264743BB3
Notes Application Number: CN200980152665
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150211&DB=EPODOC&CC=CN&NR=102264743B
ParticipantIDs epo_espacenet_CN102264743BB
PublicationCentury 2000
PublicationDate 20150211
PublicationDateYYYYMMDD 2015-02-11
PublicationDate_xml – month: 02
  year: 2015
  text: 20150211
  day: 11
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies UNIV ROCHESTER
RelatedCompanies_xml – name: UNIV ROCHESTER
Score 2.969999
Snippet Provided are compounds having an inhibitory effect on Mixed Lineage Kinases. Also provided are pharmaceutical compositions, methods of preparing the compounds,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title MLK inhibitors and methods of use
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150211&DB=EPODOC&locale=&CC=CN&NR=102264743B
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFH7MKepNp6JOpYr0VrQuadpDEZq2DLXdkCm7jTZNsR66YTv8932pnfO0W0jgJXnw5ctL3g-AW9OyhCNYbtDMtA0ipTCQ9B6MRCbMpDmjGVPxzlFsDd_I05ROO_C5ioVp8oR-N8kREVEC8V435_Vi_YjlN76V1V1aYNf8MZy4vt5ax3i7QYNG9z03GI_8Edc5d3msx6-uMmwsgnTpbcE2XqOZQkPw7qmolMV_SgkPYGeM0sr6EDqy7MEeX1Ve68Fu1H54Y7PFXnUE19HLs1aUH0VaqAo5WlJm2m_950qb59qyksdwEwYTPjRwrtnfxmY8Xi_LG5xAFy1-eQragNqMJISIPKMECdnJU2rL7N7M7AFxBD2D_gZB5xtH-7Cv9KQcj03zArr111JeIq_W6VWjkB9I4Xp6
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKc43nYo6L1Wkb0W7Jb08FKFpS3VrN2TK3kYvKdaHbtgO_74ntXM-7S0kcJIc-PLlJOcCcK9qWmImeqbQVDUUwnmiIOn1lYhHukoznaa6iHcOQs1_Iy8zOmvB5zoWps4T-l0nR0REJYj3qj6vl5tHLKf2rSwf4hy7Fk_e1HLkxjrG2w0aNLJjW-5k7IyZzJjFQjl8tYRhoxGkS3sHdvGKrQs0uO-2iEpZ_qcU7xD2JiitqI6gxYsudNi68loX9oPmwxubDfbKY7gNRkMpLz7yOBcVcqSoSKXf-s-ltMikVclP4M5zp8xXcK7538bmLNwsyx6cQhstfn4G0oAaOokISbKUEiRkM4upwdNHNTUGxEzoOfS2CLrYOnoDHX8ajOaj53DYgwOhM-GErKqX0K6-VvwKObaKr2vl_AAySn1t
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MLK+inhibitors+and+methods+of+use&rft.inventor=GELBARD+HARRIS+A&rft.inventor=LOWETH+COLIN+J&rft.inventor=GOODFELLOW+VAL+S&rft.inventor=DEWHURST+STEPHEN&rft.inventor=WIEMANN+TORSTEN&rft.date=2015-02-11&rft.externalDBID=B&rft.externalDocID=CN102264743BB